Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Magnetic Resonance Spectroscopy 17 Blood Specimen Collection 8 Bevacizumab 8 Temozolomide 7 Radiotherapy 5 Palliative Care 4 Surgical Procedures, Operative 3 Restraint, Physical 3 Radiation 3 Biopsy 3 Yoga 2 Standard of Care 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Psychosocial Intervention 2 Perfusion Magnetic Resonance Imaging 2 Mind-Body Therapies 2 Magnetic Resonance Imaging 2 Lomustine 2 Gadolinium DTPA 2 Elasticity Imaging Techniques 2 Early Intervention, Educational 2 Drug Therapy 2 Diet Therapy 2 Dexamethasone 2 Chemotherapy, Adjuvant 2 Aminolevulinic Acid 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Glioblastoma × Growth and Development × Clear all

NCT06781372 2025-03-13

GlioPDO

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡